Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

Long Term Study of 'Immuncell-LC Groups' and 'Non-treatment Groups' in Patient Undergo Curative Resection (PEIT, Radiofrequency Ablation [RFA] or Operation) for Hepatocellular Carcinoma in Korea

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01890291

Acronym

Immuncell-LC

Enrollment

162

Registered

2013-07-01

Start date

2013-06-30

Completion date

2016-02-29

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

Immuncell-LC, Hepatocellular carcinoma

Brief summary

To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Prior to the test, patient is fully explained about the purpose/ contents and characteristics of the testing medication, and the patient him(her)self, the guardian or the legal representative signed on written consent. * Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial.

Exclusion criteria

* Patient who is incongruent to this clinical trial by sub-investigator's opinion.

Design outcomes

Primary

Measure	Time frame	Description
To evaluate recurrence-free survival	up to 3 years	Radiological test should be operated by dynamic CT(using 64 cut), dynamic MRI or by angiography.

Secondary

Measure	Time frame
To determine the response rate to evaluate overall survival and cause specific survival and changes of Alpha feto protein (AFP) figures from baseline to the last observation date.	up to 3 years

Countries

South Korea

Outcome results